Literature DB >> 1562470

Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.

S Battersby1, B J Robertson, T J Anderson, R J King, K McPherson.   

Abstract

Steroid receptor was assessed immunohistochemically in 158 samples of normal breast for variation through the menstrual cycle. Patterns and intensity of reaction were used in a semi-quantitative scoring system to examine the influence of cycle phase, cycle type, parity and age. The changes in oestrogen receptor for natural cycle and oral contraceptive (OC) cycles indicated down-regulation by progestins. Progesterone receptor did not vary significantly in natural cycles, but increased steadily through OC cycles. This study provides strong evidence that both oestrogen and progesterone influence breast epithelium, but dissimilarities from the endometrium are apparent. The interval since pregnancy had a significant negative effect on frequency and score of oestrogen receptor and score of progesterone receptor. Multivariate analysis established the phase of cycle and OC use as independent significant influences on oestrogen receptor. The interval since pregnancy was an independent significant factor for both oestrogen and progesterone receptor presence.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Methods; Contraceptive Usage; Cytologic Effects; Cytology; Demographic Factors; Developed Countries; Endocrine System; England; Estrogens; Europe; Family Planning; Fertility; Fertility Measurements; Histochemical Effects; Histology; Hormone Receptors; Hormones; Mammary Gland Effects; Membrane Proteins; Menstrual Cycle; Menstruation; Northern Europe; Oral Contraceptives; Parity; Physiology; Population; Population Dynamics; Postpartum Women; Progestational Hormones; Progesterone; Puerperium; Reproduction; Research Methodology; Research Report; United Kingdom

Mesh:

Substances:

Year:  1992        PMID: 1562470      PMCID: PMC1977560          DOI: 10.1038/bjc.1992.122

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Oral contraceptive use influences resting breast proliferation.

Authors:  T J Anderson; S Battersby; R J King; K McPherson; J J Going
Journal:  Hum Pathol       Date:  1989-12       Impact factor: 3.466

2.  Proliferative stimuli in the normal breast: estrogens or progestins?

Authors:  K S McCarty
Journal:  Hum Pathol       Date:  1989-12       Impact factor: 3.466

3.  Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.

Authors:  J D Jacquemier; J Hassoun; M Torrente; P M Martin
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

4.  Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay.

Authors:  D A Paterson; C P Reid; T J Anderson; R A Hawkins
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

5.  Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast.

Authors:  G Williams; E Anderson; A Howell; R Watson; J Coyne; S A Roberts; C S Potten
Journal:  Int J Cancer       Date:  1991-05-10       Impact factor: 7.396

6.  Expression of the progestin-induced fatty acid synthetase in benign mastopathies and breast cancer as measured by RNA in situ hybridization.

Authors:  D Chalbos; C Escot; C Joyeux; M J Tissot-Carayon; A Pages; H Rochefort
Journal:  J Natl Cancer Inst       Date:  1990-04-04       Impact factor: 13.506

7.  The correlation of histologic changes in the human breast with the menstrual cycle.

Authors:  P M Vogel; N G Georgiade; B F Fetter; F S Vogel; K S McCarty
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

8.  Effects of progestins and menstrual cycle on fatty acid synthetase and progesterone receptor in human mammary glands.

Authors:  C Joyeux; D Chalbos; H Rochefort
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

9.  Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle.

Authors:  B A Lessey; A P Killam; D A Metzger; A F Haney; G L Greene; K S McCarty
Journal:  J Clin Endocrinol Metab       Date:  1988-08       Impact factor: 5.958

10.  Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers.

Authors:  H J Helin; M J Helle; M L Helin; J J Isola
Journal:  Am J Clin Pathol       Date:  1988-08       Impact factor: 2.493

View more
  25 in total

1.  Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

Authors:  B S Shoker; C Jarvis; R B Clarke; E Anderson; J Hewlett; M P Davies; D R Sibson; J P Sloane
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Steroid hormone receptors and their clinical significance in cancer.

Authors:  R I Nicholson; R A McClelland; J M Gee
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

3.  Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.

Authors:  Xiaohong R Yang; Jonine D Figueroa; Stephen M Hewitt; Roni T Falk; Ruth M Pfeiffer; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Montserrat Garcia-Closas; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2012-12-28       Impact factor: 4.872

4.  Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.

Authors:  Lisette M Cornelissen; Linda Henneman; Anne Paulien Drenth; Eva Schut; Roebi de Bruijn; Sjoerd Klarenbeek; Wilbert Zwart; Jos Jonkers
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-11-15       Impact factor: 2.673

Review 5.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

6.  Parity and expression of epithelial histopathologic markers in breast tissue.

Authors:  Yukiko Morimoto; Jeffrey Killeen; Brenda Y Hernandez; J Mark Cline; Gertraud Maskarinec
Journal:  Eur J Cancer Prev       Date:  2013-09       Impact factor: 2.497

7.  Expression of the estrogen receptor gene in developing and adult human breast.

Authors:  M Boyd; R H Hildebrandt; S A Bartow
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Inter-Individual Variation in Response to Estrogen in Human Breast Explants.

Authors:  Karen A Dunphy; Amye L Black; Amy L Roberts; Aman Sharma; Zida Li; Sneha Suresh; Eva P Browne; Kathleen F Arcaro; Jennifer Ser-Dolansky; Carol Bigelow; Melissa A Troester; Sallie S Schneider; Grace Makari-Judson; Giovanna M Crisi; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-03-09       Impact factor: 2.673

9.  Patterns of cyclic AMP binding in normal human breast.

Authors:  S Battersby; T J Anderson; W R Miller
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Ductal lavage is an inefficient method of biomarker measurement in high-risk women.

Authors:  Seema A Khan; Heather A Lankes; Deepa B Patil; Michele Bryk; Nanjiang Hou; David Ivancic; Ritu Nayar; Shahla Masood; Alfred Rademaker
Journal:  Cancer Prev Res (Phila)       Date:  2009-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.